Literature DB >> 16572889

Antibiotic resistance and mechanisms implicated in clinical enterococci in a Tunisian hospital.

N Klibi1, S Gharbi, A Masmoudi, K Ben Slama, P Poeta, M Zarazaga, C Fendri, A Boudabous, C Torres.   

Abstract

Susceptibility testing for 15 antibiotics was performed in a series of 191 clinical enterococci recovered in a Tunisian Hospital during 2000-2003. Species detected were the following ones (number of isolates): E. faecalis (139), E. faecium (41), E. casseliflavus (5), E. gallinarum (3), E. avium (2) and E. hirae (1). The percentages of antibiotic resistance detected were as follows (E. faecalis/ E. faecium/ other species) : penicillin (0/ 73/ 9%), tetracycline (78/ 44/ 54%), chloramphenicol (52/ 29/ 27%), erythromycin (66/ 100/ 82%), spiramycin (84/ 83/ 64%), pristinamycin (100/ 0/ 73%), trimethoprim-sulfamethoxazole (88/ 78/ 91%), rifampicin (72/ 41/ 0%), vancomycin (0/ 0/ 36%), teicoplanin (0/ 0/ 0%), high-level-resistance for gentamicin (24/ 29/ 45%), streptomycin (34/ 56/ 55%) and kanamycin (41/ 68/ 55%). Increased vancomycin minimum inhibitory concentrations (MICs) were only detected in E. casseliflavus and E. gallinarum isolates (MIC range 8-24 microg/ml). The erm(B), catA, tet(M), aac(6')-aph(2''), aph(3')-IIIa, and ant(6)-Ia genes were detected in 91%, 32%, 86%, 98%, 100%, and 72% of the E. faecium and E. faecalis isolates resistant to erythromycin, chloramphenicol, tetracycline and high-level-resistant to gentamicin, kanamycin and streptomycin, respectively. A total of 20 unrelated pulsed-field-gel-electrophoresis patterns were found in the series of 46 high-level gentamicin-resistant E. faecalis and E. faecium isolates of this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16572889     DOI: 10.1179/joc.2006.18.1.20

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  1 in total

1.  Virulence and antimicrobial resistance in enterococci isolated from urinary tract infections.

Authors:  Yaeghob Sharifi; Alka Hasani; Reza Ghotaslou; Behrouz Naghili; Mohammad Aghazadeh; Mortaza Milani; Ahad Bazmany
Journal:  Adv Pharm Bull       Date:  2013-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.